Core Laboratories (CLB) Stock Price
Core Laboratories Price
Core Laboratories (CLB) Stock | ISIN US21867A1051 | WKN 897269. The current Core Laboratories stock price is 13.34 USD (2026). Revenue is 545.7 M USD. Net income is 38.58 M USD. The P/E ratio is 16.26. Market capitalization is 627.35 M USD. Core Laboratories operates in the Energy sector.
Revenue at Core Laboratories has contracted by 0.5% per year over the past 19 years to 526.52 M USD. Earnings per share have declined at 4.2% per year over the last 19 years. Core Laboratories's net margin stands at 6%, up from 4.2% several years earlier. Core Laboratories currently offers a dividend yield of about 0.3%. The payout ratio is around 22% of earnings.
Core Laboratories stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Core Laboratories over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Core Laboratories stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Core Laboratories's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Core Laboratories Price |
|---|
Core Laboratories Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Core Laboratories Income Statement, Balance Sheet, Cash Flow Statement
| REVENUE (B USD) |
|---|
| REVENUE GROWTH (%) |
| GROSS MARGIN (%) |
| GROSS INCOME (M USD) |
| NET INCOME (M USD) |
| NET INCOME GROWTH (%) |
| DIVIDEND (USD)DIV. (USD) |
| DIVIDEND GROWTH (%)DIV. GROWTH (%) |
| SHARES (M) |
| DOCUMENTS |
| 2023 | 2024 | 2025 | 2026e | 2027e | 2028e | 2029e | 2030e |
|---|---|---|---|---|---|---|---|
| 0.51 | 0.52 | 0.53 | 0.55 | 0.52 | 0.61 | 0.63 | 0.65 |
| 4.09 | 2.75 | 0.57 | 3.61 | -5.32 | 18.99 | 2.93 | 2.85 |
| 21.41 | 19.69 | 20.53 | 19.82 | 20.93 | 17.59 | 17.09 | 16.62 |
| 109 | 103 | 108 | 108 | 108 | 108 | 108 | 108 |
| 36 | 31 | 31 | 38 | 37 | 64 | 75 | 90 |
| 89.47 | -13.89 | – | 22.58 | -2.63 | 72.97 | 17.19 | 20 |
| 0.04 | 0.04 | 0.04 | 0.04 | 0.18 | 0.33 | - | - |
| – | – | – | – | 350 | 83.33 | – | – |
| 47.52 | 47.69 | 47.03 | 47.03 | 47.03 | 47.03 | 47.03 | 47.03 |
| – | – | – | – | – | – | – | – |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Core Laboratories generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Core Laboratories retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Core Laboratories's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Core Laboratories has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Core Laboratories's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Core Laboratories stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Core Laboratories Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Core Laboratories business model & stock analysis
Core Laboratories Segments
Core Laboratories Revenue by Segment (1/2)
3 Years
5 Years
Max
Details
Core Laboratories Revenue by Segment (2/2)
3 Years
5 Years
10 Years
Max
Details
Core Laboratories Revenue by Region
3 Years
5 Years
Max
Details
Core Laboratories Eulerpool Fair Value
Core Laboratories historical P/E ratio, EBIT multiple, and P/S ratio
Core Laboratories annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Core Laboratories shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Core Laboratories Dividend History
19 years of dividend payments
Core Laboratories dividend history and estimates
Max
Details
Core Laboratories dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Core Laboratories Earnings Estimates
Core Laboratories Earnings Estimates
| Date | EPS estimate | Revenue Estimate | Quarterly report |
|---|---|---|---|
| 4/29/2026 | 0.1USD | 129.57 MUSD | 2026 Q1 |
| 2/4/2026 | 0.19USD | 132.41 MUSD | 2025 Q4 |
| 1/29/2026 | 0.19USD | 132.41 MUSD | 2025 Q4 |
| 4/24/2024 | 0.26USD | 140.39 MUSD | 2024 Q1 |
| 1/30/2024 | 0.26USD | 141.18 MUSD | 2023 Q4 |
| 7/25/2023 | 0.23USD | 136.26 MUSD | 2023 Q2 |
| 4/25/2023 | 0.19USD | 129.06 MUSD | 2023 Q1 |
| 1/31/2023 | 0.2USD | 132.71 MUSD | 2022 Q4 |
| 10/26/2022 | 0.15USD | 127.71 MUSD | 2022 Q3 |
| 7/27/2022 | 0.14USD | 123.17 MUSD | 2022 Q2 |
EESG©
Eulerpool ESG Scorecard© for the Core Laboratories stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Core Laboratories shareholder structure
| % | Name |
|---|---|
20.63265% | |
11.16801% | |
11.01702% | |
8.19507% | |
7.59782% | |
4.18726% | |
2.89935% | |
2.67106% | |
2.61857% | |
2.11606% |
Core Laboratories Executives and Management Board
Mr. Lawrence Bruno
(62)Chairman of the Supervisory Board, President, Chief Executive Officer, Chief Operating Officer · since 2015
Mr. Christopher Hill
(52)Chief Financial Officer, Senior Vice President
Ms. Gwendolyn Gresham
(54)Senior Vice President, Corporate Development and Investor Relations
Mr. Mark Tattoli
(50)Senior Vice President, General Counsel, Secretary
Ms. Martha Carnes
(61)Presiding Non-Executive Lead Independent Member of the Supervisory Board
Core Laboratories Supply Chain
Frequently asked questions about Core Laboratories
Core Laboratories stock
Core Laboratories Peer Group
Core Laboratories Ticker
All fundamentals and in-depth analysis of Core Laboratories
Our stock analysis for Core Laboratories Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Core Laboratories Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.